Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.47M | 10.79M | 9.63M | 9.42M | 7.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.47M | 10.79M | 9.63M | 9.42M | 7.36M |
| Cost of Revenue | 17.25M | 16.59M | 16.13M | 14.85M | 14.28M |
| Gross Profit | 25.22M | -5.80M | -6.50M | -5.43M | -6.92M |
| SG&A Expenses | 5.42M | 5.09M | 4.59M | 4.51M | 4.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.67M | 21.67M | 20.72M | 19.36M | 18.89M |
| Operating Income | 19.80M | -10.88M | -11.09M | -9.94M | -11.53M |
| Income Before Tax | 22.09M | -9.20M | -10.20M | -8.82M | -10.41M |
| Income Tax Expenses | -- | -- | -- | -- | -76.00K |
| Earnings from Continuing Operations | 22.09M | -9.20M | -10.20M | -8.82M | -10.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.09M | -9.20M | -10.20M | -8.82M | -10.34M |
| EBIT | 19.80M | -10.88M | -11.09M | -9.94M | -11.53M |
| EBITDA | 19.83M | -10.85M | -11.06M | -9.91M | -11.50M |
| EPS Basic | 1.30 | -0.72 | -1.33 | -1.17 | -1.58 |
| Normalized Basic EPS | 0.82 | -0.45 | -0.83 | -0.73 | -1.00 |
| EPS Diluted | 1.30 | -0.72 | -1.33 | -1.17 | -1.58 |
| Normalized Diluted EPS | 0.82 | -0.45 | -0.83 | -0.73 | -1.00 |
| Average Basic Shares Outstanding | 16.94M | 12.69M | 7.66M | 7.51M | 6.54M |
| Average Diluted Shares Outstanding | 16.94M | 12.69M | 7.66M | 7.51M | 6.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |